rs373914077

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM1BP4_StrongBP6

The NM_001199107.2(TBC1D24):​c.178C>T​(p.Arg60Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,613,588 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R60Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

TBC1D24
NM_001199107.2 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 0.978

Publications

1 publications found
Variant links:
Genes affected
TBC1D24 (HGNC:29203): (TBC1 domain family member 24) This gene encodes a protein with a conserved domain, referred to as the TBC domain, characteristic of proteins which interact with GTPases. TBC domain proteins may serve as GTPase-activating proteins for a particular group of GTPases, the Rab (Ras-related proteins in brain) small GTPases which are involved in the regulation of membrane trafficking. Mutations in this gene are associated with familial infantile myoclonic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2011]
TBC1D24 Gene-Disease associations (from GenCC):
  • DOORS syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, PanelApp Australia, G2P
  • familial infantile myoclonic epilepsy
    Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet
  • autosomal dominant nonsyndromic hearing loss 65
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • focal epilepsy-intellectual disability-cerebro-cerebellar malformation
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive myoclonic epilepsy with dystonia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 86
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 14 uncertain in NM_001199107.2
BP4
Computational evidence support a benign effect (MetaRNN=0.039612323).
BP6
Variant 16-2496326-C-T is Benign according to our data. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517. Variant chr16-2496326-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 207517.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBC1D24NM_001199107.2 linkc.178C>T p.Arg60Trp missense_variant Exon 2 of 8 ENST00000646147.1 NP_001186036.1 Q9ULP9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBC1D24ENST00000646147.1 linkc.178C>T p.Arg60Trp missense_variant Exon 2 of 8 NM_001199107.2 ENSP00000494678.1 Q9ULP9-1
ENSG00000260272ENST00000564543.1 linkc.178C>T p.Arg60Trp missense_variant Exon 1 of 3 2 ENSP00000455547.1 H3BQ06

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152232
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000225
AC:
56
AN:
248874
AF XY:
0.000318
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000348
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000162
AC:
237
AN:
1461238
Hom.:
1
Cov.:
31
AF XY:
0.000184
AC XY:
134
AN XY:
726952
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000730
AC:
63
AN:
86252
European-Finnish (FIN)
AF:
0.000133
AC:
7
AN:
52798
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000124
AC:
138
AN:
1112002
Other (OTH)
AF:
0.000132
AC:
8
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152350
Hom.:
0
Cov.:
33
AF XY:
0.000134
AC XY:
10
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41590
American (AMR)
AF:
0.0000653
AC:
1
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000827
AC:
4
AN:
4834
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000139
Hom.:
0
Bravo
AF:
0.0000604
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Apr 21, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24291220) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2019
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 03, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 1;C3892048:Autosomal dominant nonsyndromic hearing loss 65;CN236805:Caused by mutation in the TBC1 domain family, member 24 Benign:1
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.39
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.040
.;T;T;.;.;.;.
Eigen
Benign
0.13
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.64
D
LIST_S2
Pathogenic
0.98
.;.;D;D;D;D;D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.040
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L;L;.;.;L;.
PhyloP100
0.98
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.88
N;.;N;.;.;.;N
REVEL
Benign
0.12
Sift
Uncertain
0.0030
D;.;D;.;.;.;D
Sift4G
Uncertain
0.016
D;.;D;.;.;D;D
Polyphen
0.99
D;D;D;.;.;D;.
Vest4
0.40
MVP
0.73
MPC
0.83, 1.2
ClinPred
0.056
T
GERP RS
3.5
PromoterAI
-0.029
Neutral
Varity_R
0.089
gMVP
0.60
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373914077; hg19: chr16-2546327; API